Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 7/2018

08.03.2018 | Original Article

Surgical Outcomes of Pancreaticoduodenectomy for Pancreatic Cancer with Proximal Dorsal Jejunal Vein Involvement

verfasst von: Yuichi Hosokawa, Yuichi Nagakawa, Yatsuka Sahara, Chie Takishita, Tetsushi Nakajima, Yosuke Hijikata, Hiroaki Osakabe, Tomoki Shirota, Kazuhiro Saito, Hiroshi Yamaguchi, Keiichiro Inoue, Kenji Katsumata, Takayoshi Tsuchiya, Atsushi Sofuni, Takao Itoi, Akihiko Tsuchida

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Background/Purpose

The proximal jejunal vein which branches from the dorsal side of the superior mesenteric vein (SMV) usually drains the inferior pancreatoduodenal veins (IPDVs) and contacts the uncinate process of the pancreas. We focused on this vein, termed the proximal dorsal jejunal vein (PDJV), and evaluated the anatomical classification of the PDJV and surgical outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) with PDJV involvement (PDJVI).

Methods

The jejunal veins that branch from the dorsal side of the SMV above the inferior border of the duodenum are defined as PDJVs. We investigated 121 patients who underwent upfront pancreaticoduodenectomy for PDAC between 2011 and 2017; PDJVs were resected in all patients. The anatomical classification of PDJV was evaluated using multidetector computed tomography. Surgical and prognostic outcomes of pancreticoduodenectomy for PDAC with PDJVI were evaluated.

Results

The PDJVs were classified into seven types depending on the position of the first and second jejunal veins relative to the superior mesenteric artery. In all patients, the morbidity and mortality rates were 15.7 and 0.8%, respectively. The rates for parameters including SMV resection, presence of pathological T3–4, R0 resection, and 3-year survival were 46.2, 92.3, 92.3, and 61.1%, respectively, when there was PDJVI (n = 13). When there was no PDJVI (n = 108), the rates were 60.2, 93.5, 86.1, and 58.3%, respectively. Overall, there were no significant differences.

Conclusions

Pancreaticoduodenectomy with PDJV resection is feasible for PDAC with PDJVI and satisfactory overall survival rates are achievable. It may be necessary to reconsider the resectability of PDAC with PDJVI.
Literatur
1.
Zurück zum Zitat Neoptolemos JP, Stocken DD, Tudur Smith C, Bassi C, Ghaneh P, Owen E, Moore M, Padbury R, Doi R, Smith D, Büchler MW. Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: Composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer 2009;100:246–250.CrossRefPubMedPubMedCentral Neoptolemos JP, Stocken DD, Tudur Smith C, Bassi C, Ghaneh P, Owen E, Moore M, Padbury R, Doi R, Smith D, Büchler MW. Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: Composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer 2009;100:246–250.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. JAMA 2007;297:267–277.CrossRefPubMed Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. JAMA 2007;297:267–277.CrossRefPubMed
3.
Zurück zum Zitat Herman JM, Swartz MJ, Hsu CC, Winter J, Pawlik TM, Sugar E, Robinson R, Laheru DA, Jaffee E, Hruban RH, Campbell KA, Wolfgang CL, Asrari F, Donehower R, Hidalgo M, Diaz LA Jr, Yeo C, Cameron JL, Schulick RD, Abrams R. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: Results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol 2008;26:3503–310.CrossRefPubMedPubMedCentral Herman JM, Swartz MJ, Hsu CC, Winter J, Pawlik TM, Sugar E, Robinson R, Laheru DA, Jaffee E, Hruban RH, Campbell KA, Wolfgang CL, Asrari F, Donehower R, Hidalgo M, Diaz LA Jr, Yeo C, Cameron JL, Schulick RD, Abrams R. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: Results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol 2008;26:3503–310.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Ueno H, Kosuge T, Matsuyama Y, Yamamoto J, Nakao A, Egawa S, Doi R, Monden M, Hatori T, Tanaka M, Shimada M, Kanemitsu K. A randomized phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer 2009;101:908–915.CrossRefPubMedPubMedCentral Ueno H, Kosuge T, Matsuyama Y, Yamamoto J, Nakao A, Egawa S, Doi R, Monden M, Hatori T, Tanaka M, Shimada M, Kanemitsu K. A randomized phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer 2009;101:908–915.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Demir IE, Jager C, Schlitter AM, Konukiewitz B, Stecher L, Schorn S, Tieftrunk E, Scheufele F, Calavrezos L, Schirren R, Esposito I, Weichert W, Friess H, Ceyhan GO. et al. R0 versus R1 resection matters after pancreaticoduodenectomy, and less after distal or total pancreatectomy for pancreatic cancer. An Surg. 2017. https://doi.org/10.1097/SLA.0000000000002345 Demir IE, Jager C, Schlitter AM, Konukiewitz B, Stecher L, Schorn S, Tieftrunk E, Scheufele F, Calavrezos L, Schirren R, Esposito I, Weichert W, Friess H, Ceyhan GO. et al. R0 versus R1 resection matters after pancreaticoduodenectomy, and less after distal or total pancreatectomy for pancreatic cancer. An Surg. 2017. https://​doi.​org/​10.​1097/​SLA.​0000000000002345​
7.
Zurück zum Zitat Japan Pancreas Society. Classification of Pancreatic Carcinoma. Fourth English Edition. 2017 Japan Pancreas Society. Classification of Pancreatic Carcinoma. Fourth English Edition. 2017
8.
Zurück zum Zitat Kaneoka Y, Yamaguchi A, Isogai M. Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection. Surgery 2009;145:417–425.CrossRefPubMed Kaneoka Y, Yamaguchi A, Isogai M. Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection. Surgery 2009;145:417–425.CrossRefPubMed
9.
Zurück zum Zitat Hartel M, Niedergethmann M, Farag-Soliman M, Sturm JW, Richter A, Trede M, Post, S. Benefit of venous resection for ductal adenocarcinoma of the pancreatic head. Eur J Surg 2002;168:707–712.CrossRefPubMed Hartel M, Niedergethmann M, Farag-Soliman M, Sturm JW, Richter A, Trede M, Post, S. Benefit of venous resection for ductal adenocarcinoma of the pancreatic head. Eur J Surg 2002;168:707–712.CrossRefPubMed
10.
Zurück zum Zitat Toomy P, Hernandez J, Morton C, Duce L, Farrior T, Villadolid D, Ross S, Rosemurgy A. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile. Am Surg 2009;75:804–809. Toomy P, Hernandez J, Morton C, Duce L, Farrior T, Villadolid D, Ross S, Rosemurgy A. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile. Am Surg 2009;75:804–809.
11.
Zurück zum Zitat Nagakawa Y, Hosokawa Y, Osakabe H, Sahara Y, Takishita C, Nakajima T, Hijikata Y, Kasahara K, Kasuhiko K, Saito K, Tsuchida A. Pancreaticoduodenectomy with right-oblique posterior dissection of superior extrapancreatic nerve plexus invasion. Hepatogastroenterology 2014;61(136):2371–2376PubMed Nagakawa Y, Hosokawa Y, Osakabe H, Sahara Y, Takishita C, Nakajima T, Hijikata Y, Kasahara K, Kasuhiko K, Saito K, Tsuchida A. Pancreaticoduodenectomy with right-oblique posterior dissection of superior extrapancreatic nerve plexus invasion. Hepatogastroenterology 2014;61(136):2371–2376PubMed
12.
Zurück zum Zitat Nakamura M, Nakashima H, Tsutsumi K, Matsumoto H, Muta Y, Ueno D, Yoshida K, Hino K, Urakami A, Tanaka M. First jejunal vein oriented mesenteric excision for pancreatoduodenectomy. J Gastroenterol 2013;48(8):989–995.CrossRefPubMed Nakamura M, Nakashima H, Tsutsumi K, Matsumoto H, Muta Y, Ueno D, Yoshida K, Hino K, Urakami A, Tanaka M. First jejunal vein oriented mesenteric excision for pancreatoduodenectomy. J Gastroenterol 2013;48(8):989–995.CrossRefPubMed
13.
Zurück zum Zitat Yamada Y, Mori H, Kiyosue H, Matsumoto S, Hori Y, Maeda T. CT assessment of the inferior peripancreatic veins: clinical significance. AJR Am J Roentgenol 2000;174:677–684.CrossRefPubMed Yamada Y, Mori H, Kiyosue H, Matsumoto S, Hori Y, Maeda T. CT assessment of the inferior peripancreatic veins: clinical significance. AJR Am J Roentgenol 2000;174:677–684.CrossRefPubMed
14.
Zurück zum Zitat Ibukuro K, Tsukiyama T, Mori K, Inoue Y. Peripancreatic veins on thin-section (3 mm) helical CT. AJR Am J Roentgenol 1996;167:1003–1008.CrossRefPubMed Ibukuro K, Tsukiyama T, Mori K, Inoue Y. Peripancreatic veins on thin-section (3 mm) helical CT. AJR Am J Roentgenol 1996;167:1003–1008.CrossRefPubMed
15.
Zurück zum Zitat Kim HJ, Ko YT, Lim JW, Lee DH. Radiologic anatomy of the superior mesenteric vein and branching patterns of the first jejunal trunk: evaluation using multi-detector row CT venography. Surg Radiol Anat 2007;29:67–75.CrossRefPubMed Kim HJ, Ko YT, Lim JW, Lee DH. Radiologic anatomy of the superior mesenteric vein and branching patterns of the first jejunal trunk: evaluation using multi-detector row CT venography. Surg Radiol Anat 2007;29:67–75.CrossRefPubMed
16.
Zurück zum Zitat Papavasiliou P, Arrangoiz R, Zhu F, Chun YS, Edwards K, Hoffman JP. The anatomic course of the first jejunal branch of the superior mesenteric vein in relation to the superior mesenteric artery. Int J Surg Oncol 2012; 2012:538769.PubMedPubMedCentral Papavasiliou P, Arrangoiz R, Zhu F, Chun YS, Edwards K, Hoffman JP. The anatomic course of the first jejunal branch of the superior mesenteric vein in relation to the superior mesenteric artery. Int J Surg Oncol 2012; 2012:538769.PubMedPubMedCentral
17.
Zurück zum Zitat Ishikawa Y, Ban D, Matsumura S, Mitsunori Y, Ochiai T, Kudo A, Tanaka S, Tanabe M. Surgical pitfalls of jejunal vein anatomy in pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci 2017;24:397–400.CrossRef Ishikawa Y, Ban D, Matsumura S, Mitsunori Y, Ochiai T, Kudo A, Tanaka S, Tanabe M. Surgical pitfalls of jejunal vein anatomy in pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci 2017;24:397–400.CrossRef
Metadaten
Titel
Surgical Outcomes of Pancreaticoduodenectomy for Pancreatic Cancer with Proximal Dorsal Jejunal Vein Involvement
verfasst von
Yuichi Hosokawa
Yuichi Nagakawa
Yatsuka Sahara
Chie Takishita
Tetsushi Nakajima
Yosuke Hijikata
Hiroaki Osakabe
Tomoki Shirota
Kazuhiro Saito
Hiroshi Yamaguchi
Keiichiro Inoue
Kenji Katsumata
Takayoshi Tsuchiya
Atsushi Sofuni
Takao Itoi
Akihiko Tsuchida
Publikationsdatum
08.03.2018
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 7/2018
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-018-3722-0

Weitere Artikel der Ausgabe 7/2018

Journal of Gastrointestinal Surgery 7/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.